Athira Pharma Ownership | Who Owns Athira Pharma?


OverviewForecastFinancialsChart

Athira Pharma Ownership Summary


Athira Pharma is owned by 44.78% institutional investors, 8.70% insiders, and 46.52% retail investors. Perceptive advisors is the largest institutional shareholder, holding 13.82% of ATHA shares. Simplify Propel Opportunities ETF is the top mutual fund, with 3.82% of its assets in Athira Pharma shares.

ATHA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAthira Pharma44.78%8.70%46.52%
SectorHealthcare Stocks 218.58%11.00%-129.58%
IndustryBiotech Stocks 296.15%10.91%-207.06%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Perceptive advisors5.40M13.82%$1.63M
Bml capital management3.23M8.26%$975.66K
Vanguard group1.56M4.04%$913.75K
Propel bio management1.49M3.82%$450.82K
Simplify asset management1.49M3.82%$450.82K
Blackrock676.24K1.76%$1.79M
Tang capital management600.00K1.53%$181.20K
Jacobs levy equity management506.81K1.32%$1.34M
Acadian asset management405.48K1.04%$120.00K
Pathstone372.20K0.97%$218.37K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management3.23M0.74%$975.66K
Propel bio management1.49M0.55%$450.82K
Perceptive advisors5.40M0.06%$1.63M
Simplify asset management1.49M0.02%$450.82K
Tang capital management600.00K0.01%$181.20K
Integrity financial corp /wa52.90K0.01%$15.98K
Invst27.00K0.01%$67.77K
Jacobs levy equity management506.81K0.01%$1.34M
Laird norton trust company127.31K0.01%$38.45K
Ewa35.77K0.00%$10.80K

Top Buyers

HolderShares% AssetsChange
Royal bank of canada183.02K-174.68K
Ubs group86.98K-75.15K
Ewa35.77K0.00%35.77K
Susquehanna group, llp49.28K-30.93K
Bml capital management3.23M0.74%30.00K

Top Sellers

HolderShares% AssetsChange
Baker bros. advisors lp---3.15M
Wasatch advisors lp---1.30M
Dimensional fund advisors lp---321.45K
Two sigma investments, lp---258.47K
Bristlecone advisors---252.20K

New Positions

HolderShares% AssetsChangeValue
Ewa35.77K0.00%35.77K$10.80K
Invst27.00K0.01%27.00K$67.77K
Two sigma securities11.68K0.00%11.68K$3.53K
Raymond james financial5.50K-5.50K$1.66K
Bnp paribas arbitrage, snc1.36K-1.36K$798.00

Sold Out

HolderChange
Citigroup-75.00
Householder group estate & retirement specialist-150.00
Mather group, llc.-175.00
Wells fargo & company/mn-238.00
Macquarie group-520.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202550-7.41%17,507,224-0.33%442.21%1788.89%6-66.67%
Mar 31, 202553-5.36%17,520,697-2.34%442.07%10-16.67%18-14.29%
Dec 31, 202454-8.47%17,895,38910.96%462.65%12-52.00%2150.00%
Sep 30, 202459-14.49%16,127,283-27.33%411.25%2566.67%14-39.13%
Jun 30, 202469-12.66%22,193,5502.25%571.79%15-58.33%2327.78%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Simplify Propel Opportunities ETF1.49M3.82%-
Vanguard US Total Market Shares ETF1.12M2.87%-
Vanguard Total Stock Mkt Idx Inv1.07M2.75%-
Wasatch Micro Cap646.90K1.68%646.90K
Wasatch Ultra Growth544.27K1.42%544.27K
Vanguard Institutional Extnd Mkt Idx Tr452.02K1.16%-
Fidelity Extended Market Index165.21K0.42%-
DFA US Small Cap I88.44K0.23%3.34K
BlackRock Extended Equity Market K67.36K0.18%-29.00
Bridgeway Ultra-Small Company Market67.00K0.17%-62.18K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 01, 2025CHURCH KEVIN CHIEF SCIENTIFIC OFFICERSell$2.50K
Jul 01, 2025Litton Mark James President and CEOSell$7.37K
Jul 01, 2025San Martin Javier CHIEF MEDICAL OFFICERSell$3.18K
Jul 01, 2025Worthington Mark General Counsel and CCOSell$2.50K
Jul 01, 2025Renninger Robert SVP, Finance and AccountingSell$850.27

Insider Transactions Trends


DateBuySell
2025 Q3-5
2025 Q2--
2025 Q1-5
2024 Q4--
2024 Q3-5

ATHA Ownership FAQ


Who Owns Athira Pharma?

Athira Pharma shareholders are primarily institutional investors at 44.78%, followed by 8.70% insiders and 46.52% retail investors. The average institutional ownership in Athira Pharma's industry, Biotech Stocks , is 296.15%, which Athira Pharma falls below.

Who owns the most shares of Athira Pharma?

Athira Pharma’s largest shareholders are Perceptive advisors (5.4M shares, 13.82%), Bml capital management (3.23M shares, 8.26%), and Vanguard group (1.56M shares, 4.04%). Together, they hold 26.13% of Athira Pharma’s total shares outstanding.

Does Blackrock own Athira Pharma?

Yes, BlackRock owns 1.76% of Athira Pharma, totaling 676.24K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.79M$. In the last quarter, BlackRock increased its holdings by 8.97K shares, a 1.34% change.

Who is Athira Pharma’s biggest shareholder by percentage of total assets invested?

Bml capital management is Athira Pharma’s biggest shareholder by percentage of total assets invested, with 0.74% of its assets in 3.23M Athira Pharma shares, valued at 975.66K$.

Who is the top mutual fund holder of Athira Pharma shares?

Simplify Propel Opportunities ETF is the top mutual fund holder of Athira Pharma shares, with 3.82% of its total shares outstanding invested in 1.49M Athira Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools